Mutational Analysis of Triple-Negative Breast Cancer Using Targeted Kinome Sequencing

PURPOSE: Triple-negative breast cancer (TNBC) does not have defined therapeutic targets and is currently treated with chemotherapy only. Kinase dysregulation triggers cancer cell proliferation and metastasis and is a crucial therapeutic target for cancer. In this study, targeted kinome sequencing of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Tae-Kyung, Lee, Woo Seung, Kim, Jisun, Kim, Min Kyoon, Park, In-Ae, Kim, Ju Han, Han, Wonshik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250872/
https://www.ncbi.nlm.nih.gov/pubmed/35657000
http://dx.doi.org/10.4048/jbc.2022.25.e15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250872/
https://www.ncbi.nlm.nih.gov/pubmed/35657000
http://dx.doi.org/10.4048/jbc.2022.25.e15

Ejemplares similares